Skip to content

Clinical trials

Phase 2 Neoplasms by Site trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20103
20112
20141
20161
20171
20214
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Recruiting4
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Alessandro D'Agnolo1
Boston Scientific Corporation1
Cogent Biosciences, Inc.1
Corcept Therapeutics1
Dendreon1
Eli Lilly and Company1
Genelux Corporation1
Hoffmann-La Roche1
NiKang Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site18
Neoplasms17
Digestive System Diseases7
Carcinoma6
Digestive System Neoplasms6
Neoplasms by Histologic Type5
Adenocarcinoma4
Gastrointestinal Diseases4
Urogenital Neoplasms4
Bronchial Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.